Oral Wegovy becomes the first GLP-1 pill indicated for obesity, distinct from Rybelsus, which remains positioned for type 2 diabetes treatment. Daily administration improves acceptability for ...
FDA-approved oral Wegovy (semaglutide) introduces daily administration for chronic weight management, offering weight-loss ...
Widespread skepticism persists about pharmacy-counter pricing, with distrust concentrated among those reporting price ...
UnitedHealthcare’s Doula Support introduces a covered doula benefit in eligible employer plans, scaling in phases to reach ...
Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...
Those days and weeks after a hospitalization are often a demanding, sometimes confusing time for patients, their loved ones ...
Postdischarge adverse drug event risk is amplified by frequent medication changes, formulary substitutions, and insurance ...
Fiscal stress reflects rates lagging medical trend; behavioral health utilization far exceeded assumptions (30% vs 3.5%–4%), ...
This month, the Florida Department of Health dramatically reduced the eligibility for their AIDS Drug Assistance Program ...
A TOPOGRAPH-based hierarchy stratifies biomarker–drug pairs from regulatory/positive trial evidence (tiers 1–3A) to ...
Lynavoy is used to treat cholestatic pruritus, an extreme itch that affects almost 90% of patients with primary biliary ...
FDA approval covers adults and adolescents ≥12 years (≥88 lbs) with moderate-to-severe plaque psoriasis requiring systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results